Page last updated: 2024-08-16

resveratrol and carvedilol

resveratrol has been researched along with carvedilol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Gallardo-Godoy, A; Gever, JR; Ghaemmaghami, S; Irwin, JJ; Jacobson, MP; Li, Z; Prusiner, SB; Rao, S; Renslo, AR; Silber, BM; Widjaja, K	1
Abdollahi, M; Saeidnia, S	1
Ahmad, R; Alanazi, A; Alhusaini, A; Fadda, L	1

Reviews

1 review(s) available for resveratrol and carvedilol

Article	Year
Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases	2013

Article

Year

Toxicological and pharmacological concerns on oxidative stress and related diseases.

Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3

Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases

2013

Other Studies

2 other study(ies) available for resveratrol and carvedilol

Article	Year
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells. Bioorganic & medicinal chemistry, 2013, Dec-15, Volume: 21, Issue:24 Topics: Animals; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Mice; Molecular Structure; PrPSc Proteins; Small Molecule Libraries; Structure-Activity Relationship	2013
Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats. Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:7 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotoxicity; Carvedilol; Caspase 3; Doxorubicin; Drug Therapy, Combination; Heart; Liposomes; Male; Myocardium; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Transforming Growth Factor beta1	2020

Article

Year

Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.

Bioorganic & medicinal chemistry, 2013, Dec-15, Volume: 21, Issue:24

Topics: Animals; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Mice; Molecular Structure; PrPSc Proteins; Small Molecule Libraries; Structure-Activity Relationship

2013

Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats.

Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:7

Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotoxicity; Carvedilol; Caspase 3; Doxorubicin; Drug Therapy, Combination; Heart; Liposomes; Male; Myocardium; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Transforming Growth Factor beta1

2020